» Articles » PMID: 37907704

Causal Relationship Between Psychiatric Traits and Temporomandibular Disorders: a Bidirectional Two-sample Mendelian Randomization Study

Overview
Specialty Dentistry
Date 2023 Nov 1
PMID 37907704
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study was to investigate the causal relationship between temporomandibular disorders (TMD) and psychiatric disorders by Mendelian randomization (MR) analysis.

Materials And Methods: A two-sample bidirectional MR analysis was adopted to systematically explore the causal relationship between TMD and eight psychiatric traits, including anxiety disorder (AD), panic disorder (PD), major depressive disorder (MDD), neuroticism, attention deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD), bipolar disorder (BIP), and schizophrenia (SCZ). Inverse variance weighted (IVW), weighted median, and MR-Egger regression were used in my study. Furthermore, we also performed three sensitivity analyses to illustrate the reliability of the analysis.

Results: Two psychiatric traits have risk effects on TMD: PD (OR = 1.118, 95% CI: 1.047-1.194, P = 8.161 × 10, MDD (OR = 1.961, 95% CI: 1.450-2.653, P = 1.230 × 10). Despite not surpassing the strict Bonferroni correction applied (P > 0.00625), we could think that there was a suggestive causal effect of neuroticism and SCZ increasing the risk of TMD. On the reverse MR analysis, we found no significant evidence of causal effects of TMD on these psychiatric traits. Except for heterogeneity in the causal analysis for SCZ on TMD, no heterogeneity and horizontal pleiotropy were detected in the other analyses.

Conclusions: Our two-sample MR study has provided further evidence of PD and MDD being related to a higher risk of TMD.

Clinical Relevance: These findings highlight the importance of closely monitoring mental traits during future TMD treatments to prevent an increased risk of TMD.

Citing Articles

Temporomandibular disorders and mental health: shared etiologies and treatment approaches.

Wan J, Lin J, Zha T, Ciruela F, Jiang S, Wu Z J Headache Pain. 2025; 26(1):52.

PMID: 40075300 PMC: 11899861. DOI: 10.1186/s10194-025-01985-6.


Mechanisms for Orofacial Pain: Roles of Immunomodulation, Metabolic Reprogramming, Oxidative Stress and Epigenetic Regulation.

Khan S, Tao F Biomedicines. 2025; 13(2).

PMID: 40002847 PMC: 11853523. DOI: 10.3390/biomedicines13020434.


Is there a causal association between temporomandibular disorders and COVID-19 risk? A genetic instrumental variables analysis.

Chen J J Oral Facial Pain Headache. 2025; 38(2):98-110.

PMID: 39801100 PMC: 11810676. DOI: 10.22514/jofph.2024.018.


The potential association between sedentary behaviors and risk of temporomandibular disorders: evidence from Mendelian randomization analysis.

Zhu J, Yuan X, Zhang Y J Oral Facial Pain Headache. 2025; 38(4):91-100.

PMID: 39800960 PMC: 11810678. DOI: 10.22514/jofph.2024.042.


Assessing the Causal Relationship Between Immune Cells and Temporomandibular Related Pain by Bi‑Directional Mendelian Randomization Analysis.

He J, Chen X J Pain Res. 2024; 17:3791-3800.

PMID: 39574830 PMC: 11579143. DOI: 10.2147/JPR.S486817.


References
1.
Rener-Sitar K, celebic A, Mehulic K, Petricevic N . Factors related to oral health related quality of life in TMD patients. Coll Antropol. 2013; 37(2):407-13. View

2.
Bair M, Wu J, Damush T, Sutherland J, Kroenke K . Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med. 2008; 70(8):890-7. PMC: 2902727. DOI: 10.1097/PSY.0b013e318185c510. View

3.
Rehm J, Shield K . Global Burden of Disease and the Impact of Mental and Addictive Disorders. Curr Psychiatry Rep. 2019; 21(2):10. DOI: 10.1007/s11920-019-0997-0. View

4.
Baxter A, Scott K, Vos T, Whiteford H . Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2012; 43(5):897-910. DOI: 10.1017/S003329171200147X. View

5.
Baranova A, Zhao Y, Cao H, Zhang F . Causal associations between major depressive disorder and COVID-19. Gen Psychiatr. 2023; 36(2):e101006. PMC: 10083530. DOI: 10.1136/gpsych-2022-101006. View